Felix Breyer, PhD

Associate, London, UK

Felix is an Associate at Arix Bioscience and joined the investment team in March 2021. He is currently a Board Observer at several portfolio companies and previously held a Board Observer role at Pyxis Oncology. Prior to Arix, Felix completed his PhD in biochemistry at University College London. His doctoral research at The Francis Crick Institute was supported by a Boehringer Ingelheim Fonds Fellowship and focused on innate immune pathways underlying infection. Alongside his PhD, Felix was President of GapSummit 2018, the world’s first intergenerational biotech leadership forum that connected industry leaders with the next generation of biotech pioneers. Felix holds a First Class Honours degree with distinction in biochemistry from the University of Dundee and published research in multiple journals, including The EMBO Journal and the Journal of Experimental Medicine.